Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Mitochondrial dysfunction and Alzheimer's disease.

Chen X, Stern D, Yan SD.

Curr Alzheimer Res. 2006 Dec;3(5):515-20. Review.

PMID:
17168650
2.
3.

Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide.

Chen JX, Yan SD.

Expert Rev Neurother. 2007 Nov;7(11):1517-25. Review.

PMID:
17997700
4.

Role of mitochondrial amyloid-beta in Alzheimer's disease.

Chen JX, Yan SS.

J Alzheimers Dis. 2010;20 Suppl 2:S569-78. doi: 10.3233/JAD-2010-100357. Review.

PMID:
20463403
5.

ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.

Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, Wu H.

Science. 2004 Apr 16;304(5669):448-52.

6.

Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.

Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, Bradshaw PC.

J Alzheimers Dis. 2010;20 Suppl 2:S535-50. doi: 10.3233/JAD-2010-100342.

PMID:
20463404
7.

Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.

Dutescu RM, Li QX, Crowston J, Masters CL, Baird PN, Culvenor JG.

Graefes Arch Clin Exp Ophthalmol. 2009 Sep;247(9):1213-21. doi: 10.1007/s00417-009-1060-3. Epub 2009 Mar 7.

PMID:
19271231
8.

Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease.

Antequera D, Vargas T, Ugalde C, Spuch C, Molina JA, Ferrer I, Bermejo-Pareja F, Carro E.

Neurobiol Dis. 2009 Oct;36(1):42-50. doi: 10.1016/j.nbd.2009.06.018. Epub 2009 Jul 14.

PMID:
19607917
9.

Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.

Anandatheerthavarada HK, Devi L.

Neuroscientist. 2007 Dec;13(6):626-38. Epub 2007 Oct 2. Review.

PMID:
17911214
10.
11.

Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.

Hauptmann S, Scherping I, Dröse S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Müller WE.

Neurobiol Aging. 2009 Oct;30(10):1574-86. doi: 10.1016/j.neurobiolaging.2007.12.005. Epub 2008 Mar 4.

PMID:
18295378
12.

ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction.

Takuma K, Yao J, Huang J, Xu H, Chen X, Luddy J, Trillat AC, Stern DM, Arancio O, Yan SS.

FASEB J. 2005 Apr;19(6):597-8. Epub 2005 Jan 21.

PMID:
15665036
13.

GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.

Tian J, Shi J, Zhang L, Yin J, Hu Q, Xu Y, Sheng S, Wang P, Ren Y, Wang R, Wang Y.

Curr Alzheimer Res. 2009 Apr;6(2):118-31.

PMID:
19355846
14.

Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.

Shin RW, Ogino K, Shimabuku A, Taki T, Nakashima H, Ishihara T, Kitamoto T.

Acta Neuropathol. 2007 Jun;113(6):627-36. Epub 2007 Mar 13.

PMID:
17431643
15.

ABAD: a potential therapeutic target for Abeta-induced mitochondrial dysfunction in Alzheimer's disease.

Marques AT, Fernandes PA, Ramos MJ.

Mini Rev Med Chem. 2009 Jul;9(8):1002-8.

PMID:
19601895
16.

Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice.

Eckert A, Hauptmann S, Scherping I, Rhein V, Müller-Spahn F, Götz J, Müller WE.

Neurodegener Dis. 2008;5(3-4):157-9. doi: 10.1159/000113689. Epub 2008 Mar 6.

PMID:
18322377
17.
18.
19.

Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.

Pihlaja R, Koistinaho J, Malm T, Sikkilä H, Vainio S, Koistinaho M.

Glia. 2008 Jan 15;56(2):154-63.

PMID:
18004725
20.

Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.

Aliyev A, Chen SG, Seyidova D, Smith MA, Perry G, de la Torre J, Aliev G.

J Neurol Sci. 2005 Mar 15;229-230:285-92. Epub 2004 Dec 23.

PMID:
15760652

Supplemental Content

Support Center